Related Experiment Video
Updated: May 7, 2026

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
Multiple sclerosis and cancer: when two wrongs make a right?
Ben Deery1, Vicki A Anderson, Mardee Greenham
1Psychology Department, Royal Children's Hospital , Melbourne , Australia.
Introduction:
Current treatments for multiple sclerosis (MS) remain partially successful, with certain patients remaining treatment resistant. A recent treatment, known as 'immunoablation' has been used in severe cases of adult MS with promising results. However, due to its high risk and reservation for severe or refractory cases, its full potential remains unknown.
Methods:
We report the case of MM, a 14-year-old boy diagnosed with MS and a concurrent diagnosis of Hodgkin's lymphoma.
Results:
After receiving aggressive chemotherapy (immunoablation) for Hodgkin's lymphoma, MM's MS symptoms appear to have remitted, and he has remained progression- and disease activity-free for over six years.
Discussion:
This case study will focus on MM's cognitive and behavioural development over this time, but will also discuss treatment implications raised by this rare case.
Insights
Immunoablation, a potent cancer therapy, led to a surprising six-year remission of multiple sclerosis (MS) symptoms in a teenage boy. This case highlights the potential of aggressive chemotherapy in treating refractory pediatric MS.
Area of Science:
- Neurology
- Pediatric Oncology
- Immunology
Background:
- Multiple sclerosis (MS) treatments are not universally effective, leaving some patients with refractory disease.
- Immunoablation, a high-risk therapy, shows promise in severe adult MS but its potential in pediatric cases is largely unexplored.
Observation:
- A 14-year-old male (MM) with a new diagnosis of MS also presented with Hodgkin's lymphoma.
- MM underwent aggressive chemotherapy, a form of immunoablation, for his lymphoma.
Findings:
- Following chemotherapy, MM experienced complete remission of his MS symptoms.
- He has remained free of MS progression and disease activity for over six years.
Implications:
- This case suggests a potential therapeutic role for immunoablation in refractory pediatric MS.
- Further investigation is warranted to understand the long-term effects and cognitive/behavioral development in such cases.
More Related Videos
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Multiple Sclerosis l: Introduction
Cancer
Psychoneuroimmunology: Diabetes and Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

